End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.49 CNY | +1.64% | +5.95% | +5.81% |
Apr. 23 | Cisen Pharmaceutical Names Chief Financial Officer | MT |
Apr. 22 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 4.07B 561M | Sales 2023 | 4.46B 616M | Capitalization | 6.6B 911M |
---|---|---|---|---|---|
Net income 2022 | 350M 48.31M | Net income 2023 | 521M 71.91M | EV / Sales 2022 | 0.75 x |
Net cash position 2022 | 2.63B 362M | Net cash position 2023 | 2.45B 338M | EV / Sales 2023 | 0.93 x |
P/E ratio 2022 |
16.4
x | P/E ratio 2023 |
12.7
x | Employees | 3,413 |
Yield 2022 |
2.66% | Yield 2023 |
-
| Free-Float | 37.54% |
1 day | +1.64% | ||
1 week | +5.95% | ||
Current month | +7.87% | ||
1 month | +9.47% | ||
3 months | +5.81% | ||
6 months | +23.03% | ||
Current year | +5.81% |
Managers | Title | Age | Since |
---|---|---|---|
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
En Long Zhao
CHM | Chairman | 45 | 04-06-30 |
Xiang Liu
BRD | Director/Board Member | 35 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
BRD | Director/Board Member | 59 | 17-11-27 |
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
Hong Cai
BRD | Director/Board Member | 63 | 20-12-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 15.49 | +1.64% | 10,423,500 |
24-04-22 | 15.24 | +2.63% | 4,286,200 |
24-04-19 | 14.85 | +0.54% | 2,397,939 |
24-04-18 | 14.77 | -1.40% | 2,923,481 |
24-04-17 | 14.98 | +2.46% | 3,870,760 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+5.81% | 964M | |
+17.97% | 42.77B | |
+20.21% | 22.23B | |
+12.68% | 14.44B | |
+12.19% | 13.05B | |
+35.45% | 11.59B | |
-8.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+5.03% | 4.97B |
- Stock Market
- Equities
- 603367 Stock